YAYasmina Aguemon

Yasmina Aguemon

*This is an algorithmically generated author record based on publicly available information.

Yasmina Aguemon has a total of 4 co-authors. Here are the top co-authors by number of shared publications:

  • Florian Le Bras

    Affiliation BIOS EA 4691, Biomatériaux et Inflammation en Site Osseux, SFR CAP Santé, FED 4231, Université de Reims Champagne Ardenne, Reims, France

    1 shared publication
  • Gaëlle Carré

    Biomatériaux et Inflammation en Site Osseux (EA 4691 BIOS), SFR CAP-Santé, UFR de Pharmacie, Université de Reims Champagne-Ardenne, 51095 Reims, France

    1 shared publication
  • Marie-Paule Gelle

    Affiliations BIOS EA 4691, Biomatériaux et Inflammation en Site Osseux, SFR CAP Santé, FED 4231, Université de Reims Champagne Ardenne, Reims, France, UFR Odontologie, Université de Reims Champagne Ardenne, Reims, France, Pôle de Médecine Bucco-Dentaire, Centre Hospitalier Universitaire de Reims, Reims, France

    1 shared publication
  • Marius Colin

    Université de Reims Champagne-Ardenne, URBIOS, Reims, France

    1 shared publication

Latest Publications

  • Open Access

    Inactivation of Enveloped Bovine Viral Diarrhea Virus and Non-Enveloped Porcine Parvovirus Using Low-Pressure Non-Thermal Plasma

    by Florian Le Bras, Gaëlle Carré, Yasmina Aguemon, Marius Colin, Marie-Paule Gellé

    As the worldwide population has been experiencing since 2020, viruses represent a serious threat to global well-being. To avoid viral transmission through surgery or medical examination, sterilization of medical material is needed. From emerging sterilization processes, the use of non-thermal plasma (NTP) arises as a promising technique to efficiently reduce microbial burden on medical devices, including new complex polymers as thermosensitive ones. Thus, we evaluated the antiviral efficacy of a low-pressure NTP process taking place in a sealed bag. For this purpose, two different plasmas, O2 100% plasma and Ar 80%–O2 20% plasma, were tested against two viruses: the bovine viral diarrhea virus and the porcine parvovirus, surrogates of human hepatitis C virus and human parvovirus B19, respectively. The efficacy of both NTP treatments on viral load can be detected after only five minutes. Moreover, the longer the NTP treatments last, the more the load decreases. The most effective load reduction was obtained with a 120-min O2 plasma treatment inducing a minimum of four-log viral load reduction. So, this process demonstrated strong virucidal capacity inside a sealed bag and represents a very interesting opportunity in the field of fragile medical devices sterilization or disinfection.